Humacyte (HUMA) Revenue & Revenue Breakdown
Humacyte Revenue Highlights
Latest Revenue (Y)
$2.04M
Latest Revenue (Q)
$495.00K
Humacyte Revenue by Period
Humacyte Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $2.04M | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $1.56M | 23.91% |
| 2021-12-31 | $1.26M | -15.29% |
| 2020-12-31 | $1.49M | -75.90% |
| 2019-12-31 | $6.19M | - |
Humacyte generated $2.04M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 136.69% compared to the same period a year ago.
Humacyte Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $495.00K | 6.00% |
| 2025-12-31 | $467.00K | -37.98% |
| 2025-09-30 | $753.00K | 150.17% |
| 2025-06-30 | $301.00K | -41.78% |
| 2025-03-31 | $517.00K | -92.85% |
| 2024-12-31 | $7.23M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $31.00K | -97.62% |
| 2022-06-30 | $1.30M | 458.37% |
| 2022-03-31 | $233.00K | 31.64% |
| 2021-12-31 | $177.00K | -26.56% |
| 2021-09-30 | $241.00K | -65.07% |
| 2021-06-30 | $690.00K | 345.16% |
| 2021-03-31 | $155.00K | 25.00% |
| 2020-12-31 | $124.00K | -86.43% |
| 2020-09-30 | $914.00K | 361.62% |
| 2020-06-30 | $198.00K | -22.35% |
| 2020-03-31 | $255.00K | - |
Humacyte generated $495.00K in revenue during Q1 2026, up 6.00% compared to the previous quarter, and up 6.85% compared to the same period a year ago.
Humacyte Revenue Breakdown
Humacyte Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 26 | Jun 25 | Mar 25 | Sep 21 |
|---|---|---|---|---|
| Product | $493.00K | $100.00K | $147.00K | - |
| Product and Service, Other | $2.00K | $201.00K | $370.00K | - |
| Reimbursement of certain allowable costs related to grants | - | - | - | $200.00K |
Latest
Humacyte's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Product (99.60%), and Product and Service, Other (0.40%).
Humacyte Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 21 |
|---|---|
| Reimbursement of certain allowable costs related to grants | $200.00K |
Latest
Humacyte's latest quarterly revenue breakdown by geography, as of Sep 21: Reimbursement of certain allowable costs related to grants (100.00%).
Humacyte Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VNDA | Vanda Pharmaceuticals | $216.10M | $51.72M |
| ARCT | Arcturus Therapeutics | $82.03M | $2.06M |
| VYGR | Voyager Therapeutics | $40.37M | $2.59M |
| FHTX | Foghorn Therapeutics | $30.91M | $3.27M |
| TRDA | Entrada Therapeutics | $25.42M | $875.00K |
| HUMA | Humacyte | $2.04M | $495.00K |
| IMRX | Immuneering | - | - |
| NAUT | Nautilus Bio | - | - |
| SGMT | Sagimet Biosciences | - | - |
| ACHV | Achieve Life Sciences | - | - |
| AVIR | Atea Pharmaceuticals | - | - |